• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Edwards shares rise on 2017 outlook

Edwards shares rise on 2017 outlook

December 8, 2016 By Fink Densford

Edwards LifesciencesEdwards Lifesciences (NYSE:EW) shares have risen today in response to the company posting a positive outlook for 2017, despite 4th quarter numbers sliding towards the lower end of its guidance.

The company said that for the next year, it expects to bring in global sales between $3 billion and $3.4 billion, with adjusted earnings per share of between $3.30 and $3.45.

The company said it expects to see more opportunities in transcatheter aortic valve replacements, with the industry expected to exceed $5 billion by 2021. Edwards said the next year would also be a pivotal one for clinical experience in trans catheter mitral and tricuspid therapies.

“We expect another year of strong performance for Edwards Lifesciences in 2017, led by growth in sales of Sapien 3 and continued leadership in all our core businesses. We are projecting strong financial results next year while we continue to invest aggressively to provide breakthrough therapies for even more patients in need,” CEO & chair Michael Mussallem said in prepared remarks.

The news for the 4th quarter of this year wasn’t as positive, with Edwards expecting to see numbers near the lower end of its guidance, which was set between $750 and $790 million. The company said the dip was driven by lower surgical heart valve therapy sales which trended below October guidance, as well as the impact of foreign exchange.

Transcatheter heart valve therapy sales and critical care sales in Q4 look consistent with released guidance, Edwards said.

Shares have risen 7.3% so far today, up $6.11 to trade at $89.81 as of 12:46 p.m. EST.

Filed Under: Business/Financial News Tagged With: Edwards Lifesciences

More recent news

  • Penumbra completes enrollment in pulmonary embolism trial
  • Zoll opens new facility in Rhode Island
  • FDA expands clearance for Inquis Medical’s Aventus thrombectomy system
  • SS Innovations completes first robotic cardiac surgery in the Americas
  • GI Windows wins FDA nod for magnet tech

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy